France· FR:64876209
SIBNAYAL 24 mEq, granulés à libération prolongée
A medicinal product containing citrate de potassium + bicarbonate de potassium, registered in France by ADVICENNE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CITRATE DE POTASSIUM + BICARBONATE DE POTASSIUM
- Manufacturer
- ADVICENNE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093022310960 sachet(s) polyéthylène téréphtalate polyester aluminium polyéthylène basse densité (PEBD)EUR 213.41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Citrate de potassium + bicarbonate de potassium in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSIBNAYALADVICENNE, Paris
- United KingdomAabKCL effervescent tabletsTriOn Pharma Ltd
- PolandKalium effervescens bezcukrowyPrzedsiębiorstwo Farmaceutyczno-Chemiczne "Synteza" Sp. z o.o.
- IcelandSibnayalAdvicenne
- SwedenSibnayal 24 mEq Depotgranulat i dospåseADVICENNE
- FinlandSibnayalADVICENNE
- IrelandSibnayal 24 mEq prolonged-release granulesAdvicenne Pharma SA
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Potassium Bpc 1968 Accord-Uk
- Greece · Exeret
- Iceland · Sibnayal
- Liechtenstein · Sibnayal
- Norway · Sibnayal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1a26704e-06f4-4223-b186-bfa4e00846f8 GET /v1/drugs/1a26704e-06f4-4223-b186-bfa4e00846f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64876209",
"date_amm": "2021-04-30",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1517",
"substance": "CITRATE DE POTASSIUM + BICARBONATE DE POTASSIUM",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "granules à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about citrate de potassium + bicarbonate de potassium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.